Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Casaluce

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Current Pharmaceutical Design|August 10, 2012
The c-Met inhibitors: a new class of drugs in the battle against advanced nonsmall-cell lung cancerAssunta Sgambato, Francesca Casaluce, Paolo Maione, et al.
Expert Opinion on Biological Therapy|September 22, 2016
Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncologyCesare Gridelli, Paolo A Ascierto, Massimo C P Barberis, et al.
Clinical Lung Cancer|February 4, 2018
Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Paul Baas, Fabrice Barlesi, et al.
Frontiers in Immunology|February 2, 2024
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern ItalyVito Longo, Carminia Maria Della Corte, Alessandro Russo, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Current Pharmaceutical Design|August 10, 2012
The c-Met inhibitors: a new class of drugs in the battle against advanced nonsmall-cell lung cancerAssunta Sgambato, Francesca Casaluce, Paolo Maione, et al.
Expert Opinion on Biological Therapy|September 22, 2016
Immunotherapy of non-small cell lung cancer: report from an international experts panel meeting of the Italian association of thoracic oncologyCesare Gridelli, Paolo A Ascierto, Massimo C P Barberis, et al.
Clinical Lung Cancer|February 4, 2018
Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic OncologyCesare Gridelli, Paul Baas, Fabrice Barlesi, et al.
Frontiers in Immunology|February 2, 2024
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern ItalyVito Longo, Carminia Maria Della Corte, Alessandro Russo, et al.
Pageof 4